GA
LOXO

Geneva Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

Geneva Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$1.55M Buy
+19,345
New +$1.07M 0.03% 278

Other funds holding LOXO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Geneva Advisors's LOXO Position: Q2 2017 in Review

Geneva Advisors opened a new position in Loxo Oncology, Inc (LOXO) in Q2 2017: 19,345 shares worth $1.55M. The stake represents 0.03% of the portfolio and ranks #278 among its holdings.

129 funds tracked by Wall St. Rank hold LOXO as of Q2 2017.

  • Geneva Advisors held 19,345 shares of Loxo Oncology, Inc worth $1.55M as of Q2 2017.
  • Loxo Oncology, Inc was a new Geneva Advisors position in Q2 2017.
  • Loxo Oncology, Inc made up 0.03% of Geneva Advisors's portfolio in Q2 2017, its #278 holding.
  • 129 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.